Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CEO

See Remarks

Chief Commercial Officer

Chief Scientific Officer

Chief Financial Officer

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 (neratinib, oral), for the patients with early stage HER2-overexpressed/amplified breast cancer; for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; and for HER2 mutation-positive solid tumors. Its products also includes PB272 (neratinib, intravenous), and PB357. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-12	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-03	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-01-03	Premium	sold	Premium	Premium	Premium	See Remarks
2024-01-03	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-01-03	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2024-01-03	Premium	sold	Premium	Premium	Premium	President and CEO
2023-12-04	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-11-07	Premium	sold	Premium	Premium	Premium	-
2023-07-03	Premium	sold	Premium	Premium	Premium	President and CEO
2023-07-03	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-07-03	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-07-03	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-07-03	Premium	sold	Premium	Premium	Premium	See Remarks
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	sold	Premium	Premium	Premium	-
2023-06-13	Premium	sold	Premium	Premium	Premium	-
2023-06-13	Premium	sold	Premium	Premium	Premium	-

PBYI - Puma Biotechnology Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for PBYI